28.Sep.2016

Development of medicine in Russia: biotechnologies for state and business needs

On September 26-27, OCT group companies took part in the 1st Biotechmed Conference which was supported by the Ministry of Industry and Trade and the Ministry of Health of the Russian Federation.

Data MATRIX, a provider of data management solutions, statistical services and software for clinical trials, was represented as a resident of Biomed-cluster at the Skolkovo booth.

Elizaveta Rozhdestvenskaya, Chief Operating Officer of Primer Capital, became a member of a panel of judges in a startup competition. Its final round followed the discussion, dedicated to the ecosystem development and startups acceleration in the biotechnology. attended the conference as a member of a panel of judges in a startup competition. During the final round of the competition a discussion took place that was dedicated to ecosystem development and biotechnology startups acceleration. To see the full recording of this discussion with speakers Ruslan Altaev (Skolkovo), Eugeny Kuznetsov (RVK), Pavel Shklyudov (IBM Watson Group), Mikhail Samsonov (R-Pharm), Leonid Levkovich-Maslyuk (ЕМС), Olga Bogonina (GE Healthcare) follow this link.

The session entitled “Important issues of pre-clinical and clinical trials of medical drugs and assessment of medical technologies efficacy” was also held on the first day of the event. “It is great that the event of such a scale enabled us to discuss the important issues as those included in this part of the conference with representatives of the Ministry of Industry and Trade and the Moscow City Health Department as speakers. Regulation of the industry as a whole and pharmacovigilance in particular, new technologies and interaction models for all clinical research market players are all equally important not only for the effective functioning of the industry, but also for its development”, comments OCT President Dmitry Sharov.

Biotechmed conference is dedicated to help Russia become a key player in the developing market of biomedical technologies. The conference is a flagship platform for discussion of relevant issues of biotechnology and medicine in the time of technology changes in Russia. Key sectors of the confrence include:

  • IT in medicine
  • Medical drug development and use
  • Personalized medicine
  • Tissue engineering and cell technology
  • Innovation medicine technology
  • Medical service market